| Oct 25 |
GSK invests $800M in manufacturing; Amgen sets small discount for Eylea biosimilar
|
| Oct 25 |
High Growth Tech Stocks To Watch In October 2024
|
| Oct 25 |
AbbVie and Richter partner for neuropsychiatric treatments
|
| Oct 24 |
AbbVie (ABBV) Outperforms Broader Market: What You Need to Know
|
| Oct 24 |
AbbVie's Emraclidine Phase 2 Trial Data in Q4 Present Major Catalyst, UBS Says
|
| Oct 24 |
AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions
|
| Oct 23 |
AbbVie: Expect A Beat-And-Raise Q3 2024
|
| Oct 23 |
Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for
|
| Oct 23 |
With 73% institutional ownership, AbbVie Inc. (NYSE:ABBV) is a favorite amongst the big guns
|
| Oct 23 |
Beat the Nasdaq With This Cash-Gushing Dividend Stock
|
